Literature DB >> 17615178

Intestinal phenotype of variable-weight cystic fibrosis knockout mice.

Juan C Canale-Zambrano1, Maya C Poffenberger, Sean M Cory, Daryl G Humes, Christina K Haston.   

Abstract

Cystic fibrosis (CF) transmembrane conductance regulator (Cftr) knockout mice present the clinical features of low body weight and intestinal disease permitting an assessment of the interrelatedness of these phenotypes in a controlled environment. To identify intestinal alterations that are affected by body weight in CF mice, the histological phenotypes of crypt-villus axis height, goblet cell hyperplasia, mast cell infiltrate, crypt cell proliferation, and apoptosis were measured in a population of 12-wk-old (C57BL/6 x BALB/cJ) F2 Cftr(tm1UNC) and non-CF mice presenting a range of body weight. In addition, cardiac blood samples were assessed, and gene expression profiling of the ileum was completed. Crypt-villus axis height decreased with increasing body weight in CF but not control mice. Intestinal crypts from CF mice had fewer apoptotic cells, per unit length, than did non-CF mice, and normalized cell proliferation was similar to control levels. Goblet cell hyperplasia and mast cell infiltration were increased in the CF intestine and identified to be independent of body weight. Blood triglyceride levels were found to be significantly lower in CF mice than in control mice but were not dependent on CF mouse weight. By expression profiling, genes of DNA replication and lipid metabolism were among those altered in CF mice relative to non-CF controls, and no differences in gene expression were measured between samples from CF mice in the 25th and 75th percentile for weight. In this CF mouse model, crypt elongation, due to an expanded proliferative zone and decreased apoptosis, was identified to be dependent on body weight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17615178     DOI: 10.1152/ajpgi.00405.2006

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  10 in total

1.  Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.

Authors:  Mark Bazett; Lisa Honeyman; Anguel N Stefanov; Christopher E Pope; Lucas R Hoffman; Christina K Haston
Journal:  Mamm Genome       Date:  2015-02-27       Impact factor: 2.957

Review 2.  Recent advances in small bowel diseases: Part II.

Authors:  Alan B R Thomson; Angeli Chopra; Michael Tom Clandinin; Hugh Freeman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

3.  Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype.

Authors:  M E Street; C Spaggiari; M A Ziveri; M Rossi; C Volta; I Viani; G L Grzincich; C Sartori; M Zanzucchi; V Raia; C Terzi; G Pisi; E Zanetti; M C S Boguszewski; T O Kamoi; S Bernasconi
Journal:  J Endocrinol Invest       Date:  2011-04-06       Impact factor: 4.256

4.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

5.  Listeria monocytogenes exploits cystic fibrosis transmembrane conductance regulator (CFTR) to escape the phagosome.

Authors:  Andrea L Radtke; Kelsi L Anderson; Michael J Davis; Matthew J DiMagno; Joel A Swanson; Mary X O'Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

6.  Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.

Authors:  Jinghua Liu; Nancy M Walker; Akifumi Ootani; Ashlee M Strubberg; Lane L Clarke
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

7.  Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.

Authors:  Nancy M Walker; Jinghua Liu; Sarah M Young; Rowena A Woode; Lane L Clarke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-12-08       Impact factor: 4.052

8.  MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice.

Authors:  Lisa Honeyman; Mark Bazett; Tomasz G Tomko; Christina K Haston
Journal:  Fibrogenesis Tissue Repair       Date:  2013-08-29

9.  SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.

Authors:  Saumel Ahmadi; Sunny Xia; Yu-Sheng Wu; Michelle Di Paola; Randolph Kissoon; Catherine Luk; Fan Lin; Kai Du; Johanna Rommens; Christine E Bear
Journal:  Elife       Date:  2018-07-13       Impact factor: 8.140

10.  Short-term CFTR inhibition reduces islet area in C57BL/6 mice.

Authors:  Dawood Khan; Ryan Kelsey; Rashmi R Maheshwari; Virginia M Stone; Annie Hasib; Fiona N Manderson Koivula; Aoife Watson; Stephen Harkin; Nigel Irwin; James A Shaw; Neville H McClenaghan; Viktória Venglovecz; Attila Ébert; Malin Flodström-Tullberg; Michael G White; Catriona Kelly
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.